查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519972

全球生物阻抗設備市場 2024-2031

Global Bioimpedance Device Market 2024-2031
出版日期: | 出版商: Orion Market Research | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

按產品類型（單頻生物阻抗設備和多頻生物阻抗設備）、模式（有線生物阻抗設備和無線生物阻抗設備）和最終用戶（醫院、專業）生物阻抗設備市場規模、佔有率和趨勢分析報告診所、復健中心等）預測期（2024-2031）

預計在預測期內（2024-2031 年）生物阻抗設備市場將以 9.6% 的複合年成長率成長。使用生物阻抗裝置取代輻射來確定身體成分，因為它們使用安全電流。它們更容易操作、更快、更緊湊，並且不需要培訓，其中一些甚至是手持式的。許多治療領域，如胃腸病學、慢性發炎、術後監測、運動科學等，都廣泛使用生物阻抗設備。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要市場趨勢
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • General Electric Company
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Inbody Co., Ltd
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Omron Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按產品類型分類的全球生物阻抗設備市場
    • 單頻生物阻抗設備
    • 多頻生物阻抗裝置
  • 按模式分類的全球生物阻抗設備市場
    • 有線生物阻抗設備
    • 無線生物阻抗設備
  • 最終用戶的全球生物阻抗設備市場
    • 醫院
    • 專科診所
    • 復健中心
    • 其他（門診手術中心）

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第 6 章：公司簡介

  • Akern Srl
  • Biodynamics Corp.
  • Bioparhom
  • Bodystat Ltd.
  • Charder Electronic Co. Ltd
  • EVOLT IOH Pty Ltd
  • Fook Tin Group Holding Ltd.
  • Fresenius Medical Care
  • ImpediMed Ltd.
  • InBody Co. Ltd.
  • Lumsail Industrial Inc.
  • Maltron International Ltd.
  • RJL Systems, Inc.
  • SELVAS AI Inc.
  • SMT Medical GmbH
  • Tanita Corp.
  • Xiaomi Inc.
Product Code: OMR2028614

Bioimpedance Device Market Size, Share & Trends Analysis Report by Product Type (Single-Frequency Bioimpedance Devices, and Multiple-Frequency Bioimpedance Devices), by Modality (Wired Bioimpedance Devices, and Wireless Bioimpedance Devices), and by End-Users (Hospitals, Specialty Clinics, Rehabilitation Centers, and Others) Forecast Period (2024-2031)

Bioimpedance device market is anticipated to grow at a CAGR of 9.6% during the forecast period (2024-2031). Bioimpedance devices are used instead of radiation to determine body composition, as they employ a safe electrical current. These are easier to operate, faster, more compact, and require no training some of them are even handheld. Numerous therapeutic domains, such as gastroenterology, chronic inflammation, postoperative surveillance, sports science, and many more, make extensive use of bioimpedance devices.

Market Dynamics

Growing demand for fitness and weight management gadgets

The gadgets' capacity to provide detailed information on body composition, a parameter that is becoming more and more important for weight management and fitness enthusiasts, led to their widespread adoption. The occurrence of long-term health conditions like diabetes and obesity is driving up demand. The percentage of muscle mass and body fat can be tracked non-invasively with bioimpedance analysis, which helps manage these disorders.

Rising usage of bioimpedance devices

Bioimpedance devices offer an incredibly attractive value proposition by putting the power of proactive monitoring firmly in the hands of the end-user in an era of cost-effective healthcare system solutions. Over the next years, it is anticipated that this trend and the expansion of preventative measures will further fuel the market for bioimpedance devices.

Market Segmentation

  • Based on product type, the market is bifurcated into single-frequency bioimpedance devices and multiple-frequency bioimpedance devices.
  • Based on modality, the market is bifurcated into wired bioimpedance devices, and wireless bioimpedance devices.
  • Based on end-users, the market is segmented into hospitals, specialty clinics, rehabilitation centers, and others including ambulatory surgical centers.

Hospitals are Projected to Emerge as the Largest Segment

Bioimpedance devices are used by doctors to conduct body composition analyses, the results of which are utilized to monitor the fluid status of critically ill patients, evaluate lung function, and provide the proper nutritional intervention. Additionally, the integration of these devices in standard hospital operations is highly promoted as they produce patient care data points with extra value.

Regional Outlook

The global bioimpedance device market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to invest in affordable healthcare devices.

  • China's large population makes it a strong market with a range of bioimpedance device manufacturers catering to varying budgets and needs. These factors can present a favorable prospect for producers of bioimpedance devices.

North America Holds Major Market Share

The presence of advanced healthcare infrastructure, high healthcare expenditure, and the growing prevalence of diabetes among the population are some of the key contributors to the high share of the regional market growth. Apart from these, the presence of major hospitals that are the primary end-users of bioimpedance devices further caters to the regional market growth.

Market Players Outlook

The major companies serving the global bioimpedance device market include Inbody Co., Ltd., General Electric Company, Omron Corp., Fresenius Medical Care, and ImpediMed Ltd. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions among others to stay competitive in the market. For instance, in September 2022, GlucoRx announced the first multi-sensor non-invasive glucose monitoring. The GlucoRx BioXensor uses patented radio frequency technology alongside a multiple-sensor approach to measure blood glucose levels every minute reliably, accurately, and non-invasively.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Market Trends
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. General Electric Company
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Inbody Co., Ltd
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Omron Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Bioimpedance Device Market by Product Type
    • 4.1.1. Single-Frequency Bioimpedance Devices
    • 4.1.2. Multiple-Frequency Bioimpedance Devices
  • 4.2. Global Bioimpedance Device Market by Modality
    • 4.2.1. Wired Bioimpedance Devices
    • 4.2.2. Wireless Bioimpedance Devices
  • 4.3. Global Bioimpedance Device Market by End-Users
    • 4.3.1. Hospitals
    • 4.3.2. Specialty Clinics
    • 4.3.3. Rehabilitation Centers
    • 4.3.4. Others (Ambulatory Surgical Centers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. Akern Srl
  • 6.2. Biodynamics Corp.
  • 6.3. Bioparhom
  • 6.4. Bodystat Ltd.
  • 6.5. Charder Electronic Co. Ltd
  • 6.6. EVOLT IOH Pty Ltd
  • 6.7. Fook Tin Group Holding Ltd.
  • 6.8. Fresenius Medical Care
  • 6.9. ImpediMed Ltd.
  • 6.10. InBody Co. Ltd.
  • 6.11. Lumsail Industrial Inc.
  • 6.12. Maltron International Ltd.
  • 6.13. RJL Systems, Inc.
  • 6.14. SELVAS AI Inc.
  • 6.15. SMT Medical GmbH
  • 6.16. Tanita Corp.
  • 6.17. Xiaomi Inc.

LIST OF TABLES

  • 1. Global Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 2. Global Single-Frequency Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 3. Global Multiple-Frequency Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 4. Global Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
  • 5. Global Wired Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 6. Global Wireless Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 7. Global Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
  • 8. Global Bioimpedance Device For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 9. Global Bioimpedance Device For Specialty Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 10. Global Bioimpedance Device For Rehabilitation Centers Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 11. Global Bioimpedance Device For Other End-Users Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 12. Global Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 13. North American Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 14. North American Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 15. North American Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
  • 16. North American Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
  • 17. European Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 18. European Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 19. European Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
  • 20. European Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
  • 21. Asia-Pacific Bioimpedance Device Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 22. Asia-Pacific Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 23. Asia-Pacific Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
  • 24. Asia-Pacific Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)
  • 25. Rest Of The World Bioimpedance Device Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 26. Rest Of The World Bioimpedance Device Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 27. Rest Of The World Bioimpedance Device Market Research And Analysis By Modality, 2023-2031 ($ Million)
  • 28. Rest Of The World Bioimpedance Device Market Research And Analysis By End-Users, 2023-2031 ($ Million)

LIST OF FIGURES

  • 1. Global Bioimpedance Device Market Share By Product Type, 2023 Vs 2031 (%)
  • 2. Global Single-Frequency Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
  • 3. Global Multiple-Frequency Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
  • 4. Global Bioimpedance Device Market Share By Modality, 2023 Vs 2031 (%)
  • 5. Global Wired Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
  • 6. Global Wireless Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
  • 7. Global Bioimpedance Device Market Share By End-Users, 2023 Vs 2031 (%)
  • 8. Global Bioimpedance Device For Hospitals Market Share By Region, 2023 Vs 2031 (%)
  • 9. Global Bioimpedance Device For Specialty Clinics Market Share By Region, 2023 Vs 2031 (%)
  • 10. Global Bioimpedance Device For Rehabilitation Centers Market Share By Region, 2023 Vs 2031 (%)
  • 11. Global Bioimpedance Device For Other End-Users Market Share By Region, 2023 Vs 2031 (%)
  • 12. Global Bioimpedance Device Market Share By Region, 2023 Vs 2031 (%)
  • 13. US Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 14. Canada Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 15. UK Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 16. France Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 17. Germany Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 18. Italy Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 19. Spain Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 20. Rest Of Europe Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 21. India Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 22. China Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 23. Japan Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 24. South Korea Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 25. Rest Of Asia-Pacific Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 26. Latin America Bioimpedance Device Market Size, 2023-2031 ($ Million)
  • 27. Middle East And Africa Bioimpedance Device Market Size, 2023-2031 ($ Million)